Puma Biotechnology Announces New Inducement Awards for Non-Executive Employees Under 2017 Incentive Plan

Reuters
05 Jun
Puma Biotechnology Announces New Inducement Awards for Non-Executive Employees Under 2017 Incentive Plan

Puma Biotechnology Inc. has announced the approval of inducement restricted stock unit awards for three new non-executive employees. The awards, covering a total of 18,250 shares of Puma common stock, were granted under the company's 2017 Employment Inducement Incentive Award Plan. The vesting schedule for these awards spans three years, with one-third of the shares vesting on the first anniversary of the award's vesting commencement date, June 1, 2025. Subsequently, one-sixth of the shares will vest on each six-month anniversary thereafter, contingent upon the employees' continued service with the company. These inducement awards were approved by Puma's Board of Directors' Compensation Committee on June 2, 2025, in line with Nasdaq Listing Rule 5635(c)(4).

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Puma Biotechnology Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20250604353607) on June 04, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10